Skip to main content

Table 3 DACT1 methylation and clinicopathologic features of breast tumors

From: DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer

Clinicopathologic features

Number (N= 134)

DACT1methylation status

Pvalue

  

Methylated

Unmethylated

 

Age (years)

≤40

11

2

9

0.229

 

> 40

86

30

56

 
 

Unknown

37

8

29

 

Tumor grade

I

7

2

5

0.425

 

II

56

21

35

 
 

III

5

1

4

 
 

Unknown

66

16

50

 

Tumor size

≤2.0 cm

44

14

30

0.21

 

≥2.0 cm, ≤5.0 cm

48

18

30

 
 

> 5.0 cm

4

0

4

 
 

unknown

38

8

30

 

Lymph node metastasis

Positive

43

16

27

0.38

 

Negative

41

12

29

 
 

Unknown

50

12

38

 

Distant metastasis

Positive

1

1

0

0.114

 

Negative

98

32

66

 
 

Unknown

35

7

28

 

ER status

Positive

45

17

28

0.274

 

Negative

29

9

20

 
 

Unknown

60

14

46

 

PR status

Positive

34

11

23

0.296

 

Negative

40

15

25

 
 

Unknown

60

14

46

 

HER2 status

Positive

42

15

27

0.148

 

Negative

28

11

17

 
 

Unknown

64

14

50

 
  1. ER, estrogen receptor; HER2, human epidermal growth factor receptor-2; PR, progesterone receptor.